Literature DB >> 793278

The immunogenicity of insulin preparations.

R E Chance, M A Root, J A Galloway.   

Abstract

Patients who had never received insulin were administered porcine or bovine Lente insulins prepared from either conventional USP-grade insulin, "single-peak" insulin (SPI), or "single-component" insulin (SCI) in an attempt to determine if insulin immunogenecity was related to the purity of various insulin preparations. Serum insulin antibody titers were monitored by a sensitive I125-insulin binding procedure. All six groups of patients had some degree of antibody formation after six months of continuous insulin administration. Based upon the percent of I125-insulin bound by the serum, the least immunogenic insulin preparation was the porcine SCI. The most immunogenic insulins were the bovine preparations, all three of which gave comparable antibody responses. The patients who received porcine USP insulin and porcine SPI had similar antibody titers, both of which were significantly higher than the titers from the patients on porcine SCI, but significantly lower than the antibody titers from the patients treated with any of the bovine preparations. The immunogenicity of bovine SCI was significantly reduced by administering multiple daily doses of the neutral regular form instead of one or two daily injections of the Lente form, Although these purer insulin preparations (SPI and SCI) are still associated with various degrees of immunogenecity, they are significant improvements for the treatment of insulin lipoatrophy and insulin allergy.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 793278

Source DB:  PubMed          Journal:  Acta Endocrinol Suppl (Copenh)        ISSN: 0300-9750


  11 in total

1.  Pancreatic polypeptide.

Authors:  T E Adrian
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1978

2.  New insulins: their role in the treatment of diabetes.

Authors:  I Caterson
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

3.  Cellular cytotoxicity to membrane-associated insulin in an autologous system.

Authors:  E R Richens; M E Seward; R W Groves
Journal:  Acta Diabetol Lat       Date:  1985 Jan-Mar

4.  Immunological properties and biological effectiveness of insulin analogues substituted at position B30.

Authors:  H P Neubauer; R Obermeier; G Schnorr
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

5.  Antibody responses following change-over to mixed species (porcine/bovine) insulins.

Authors:  M I Drury; D Cregan; R M Drury; A B Kurtz; S R Bloom; L S Gerlis
Journal:  Ir J Med Sci       Date:  1983-09       Impact factor: 1.568

Review 6.  Circulating insulin-binding antibodies.

Authors:  A B Kurtz; J D Nabarro
Journal:  Diabetologia       Date:  1980-10       Impact factor: 10.122

7.  Characterization of proinsulin-insulin intermediates in human plasma.

Authors:  C de Haën; S A Little; J M May; R H Williams
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

8.  Decrease of antibodies to insulin, proinsulin and contaminating hormones after changing treatment from conventional beef to purified pork insulin.

Authors:  A B Kurtz; J A Matthews; B E Mustaffa; P R Daggett; J D Nabarro
Journal:  Diabetologia       Date:  1980       Impact factor: 10.122

9.  Insulin binding capacity in patients changed from conventional to highly purified insulins. An indicator of likely response.

Authors:  B E Mustaffa; P R Daggett; J D Nabarro
Journal:  Diabetologia       Date:  1977-08       Impact factor: 10.122

Review 10.  New approaches to therapy and diagnosis of diabetes.

Authors:  B Hansen; A Lernmark; J H Nielsen; D Owerbach; B Welinder
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.